Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03982225

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat — AYP-101  

Moderate or Severe Submental Fullness Clinical Trial

Official title:
A Multicenter, Randomized, Subject-assessor Blind, Placebo Controlled Phase Ⅱ Study to Determine the Optimal Dose of AYP-101 S.C. Injection for the Reduction of Submental Fat

Clinical Trial Summary

Phase 2 trial to evaluate the safety and potential efficacy of three concentration of polyene phosphatidylcholine injection (AYP-101) compared to placebo for the reduction of submental fat.

Clinical Trial Description

This study is to determine the optimal dose and evaluate safety and efficacy of Polyene Phosphatidylcholine S.C injection (AYP-101) for the reduction of Submental Fat (SMF) who wish improvement in the appearance of moderate to severe convexity or fullness associated with SMF in adults. ;

Study Design

Related Conditions & MeSH terms

  • Moderate or Severe Submental Fullness
Clinical Trial Details
NCT number NCT03982225
Study type Interventional
Source AMIpharm Co., Ltd.
Contact
Status Completed
Phase Phase 2
Start date July 1, 2019
Completion date October 21, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT01546142 - Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Phase 3
Completed NCT05266729 - Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area Phase 2
Completed NCT01294644 - Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Phase 3
Completed NCT01542034 - Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Phase 3
Completed NCT02007434 - Patient Experience Study of Deoxycholic Acid Injection Phase 3
Completed NCT01305577 - Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Phase 3
Completed NCT01032889 - Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study Phase 2
Completed NCT01426373 - Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area Phase 3
Completed NCT00618722 - Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Phase 1/Phase 2
Completed NCT00618618 - Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Phase 2